Service-Based Research in Drug Development

Currently, there are still many Indonesians who have not been able to critically evaluate the viability of information on health products that promise to cure or prevent disease.

Not long ago, it was reported that the government stopped local development of a Covid-19 candidate vaccine at the phase I clinical trial stage. Subsequently, the government decided that this vaccine candidate would be developed in the context of "service-based research".

This policy needs to be assessed very carefully. If service-based research in drug development means that vaccines that have not passed the clinical trials can be used for the public while their safety and effectiveness are to be studied later, this process goes against the logical process of drug development.